Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Orally non toxic for 2,4-dihydroxybenzophenone and benzophenone-3, which are assessed as an acceptable surrogate substance for 4,4 dihydroxybenzophenone. LD50 values range from 7.7 - 11.6 g/kg in rats.

The CIR data review of benzophenone-3 (assessed to be an acceptable surrogate to 4,4 dihydroxybenzophenone) and many other benzophenone substances used in cosmetics all showed that these substances are non-toxic by dermal exposure. These materials are used as photostabilizers in cosmetics and have a photoprotective effect on the skin.

There is no indication of oral or dermal toxicity and further animal testing on this specific benzophenone is not recommended.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Version / remarks:
No data
Deviations:
not specified
GLP compliance:
not specified
Remarks:
data has been taken from a publication and GLP details were not available
Specific details on test material used for the study:
None
Species:
rat
Strain:
not specified
Sex:
not specified
Route of administration:
oral: unspecified
Sex:
not specified
Dose descriptor:
LD50
Effect level:
8 600 mg/kg bw
Based on:
test mat.
Interpretation of results:
GHS criteria not met
Conclusions:
Non toxic for 2,4-dihydroxybenzophenone, which is a surrogate substance for 4,4 dihydroxybenzophenone.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed

Acute toxicity: via dermal route

Link to relevant study records
Reference
Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
Precise details of the method used are not given in the text
Principles of method if other than guideline:
The acute dermal toxicity of Benzophenones-3 was tested in albino rabbits. The test substance was applied at various dosages to the epilated
skin of the back or flanks and held in contact for 18-24 hours; it was then washed off. Observations were made daily for signs of toxicity and irritation. Animals
were autopsied following the 5- to 7-day observation period.
GLP compliance:
not specified
Remarks:
Data taken from CIR assessment of benzophenones. Date of testing was prior to requirement for GLP study.
Test type:
standard acute method
Species:
rabbit
Strain:
other: albino
Sex:
not specified
Type of coverage:
occlusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
The test substance was applied at various dosages to the epilated skin of the back or flanks and held in contact for 18-24 hours; it was then washed off.
Observations were made daily for signs of toxicity and irritation. Animals were autopsied following the 5- to 7-day observation period.
Duration of exposure:
18 - 24 hours
Doses:
Various - 2.0 - 16.0 g/kg
Key result
Sex:
not specified
Dose descriptor:
LD50
Effect level:
> 16 other: g/kg
Based on:
test mat.
Clinical signs:
Local skin reactions, consisting of mild to moderate erythema, were observed in two animals at the 2.0 g/kg dose 24 and 48 hours following the exposure period. No significant pathology was revealed upon autopsy.
Interpretation of results:
GHS criteria not met
Conclusions:
The CIR data review of this benzophenone-3 (assessed to be an acceptable surrogate to 4,4 dihydroxybenzophenone) and many other benzophenone substances used in cosmetics all showed that these substances are non-toxic by dermal exposure. These materials are used as photostabilizers in cosmetics and have a photoprotective
effect on the skin. There is no indication of dermal toxicity and further animal testing on this specific benzophenone is not recommended.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed

Additional information

Justification for classification or non-classification